top of page
Search

The Impact of Selank on Anxiety, Depression and Pain Disorders


Selank®, an anxiolytic peptide pharmaceutical, has emerged as a promising therapeutic option with its unique combination of anxiolytic, antidepressant, and anti-asthenic attributes. Developed through a progressive journey starting with the discovery of anxiolytic potential in 1995, Selank exhibits a multifaceted pharmacological prow­ess. Selank’s potential therapeutic benefits extend to memory enhancement and cognitive functions, making it a promising candidate for improving learning and retention. Its role in protecting the immune system and reducing in­flammation in depression further highlights its versatility in addressing anxiety-asthenic disorders.


Go to Store:

https://www.thehopkinsfoundation.com/product-page/the-impact-of-selank-on-anxiety-depression-and-pain-disorders


Go to Supplements:



8 views0 comments

Recent Posts

See All

Understanding Selank:

The Hopkins Foundation’s Comprehensive Guide to Selank’s Potential Benefits for Anxiety Introduction Anxiety disorders affect millions of people worldwide, and their impact on daily life can be debili

bottom of page